(A Top Pick Nov 20/06. Up 30%.) Missed a quarter and there were competitive threats so he got out and missed the upswing.
biotechnology / pharmaceutical
Using plasma to stop bleeding in the surgical applications. 200% growth. Sells at about 20 X earnings. Management owns a big chunk. Just reported stellar numbers. Will ultimately get taken over.
biotechnology / pharmaceutical
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Omnix Biopharmaceuticals(OMRI-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Omnix Biopharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Omnix Biopharmaceuticals(OMRI-Q) Frequently Asked Questions

What is Omnix Biopharmaceuticals stock symbol?

Omnix Biopharmaceuticals is a OTC stock, trading under the symbol OMRI-Q on the (). It is usually referred to as or OMRI-Q

Is Omnix Biopharmaceuticals a buy or a sell?

In the last year, there was no coverage of Omnix Biopharmaceuticals published on Stockchase.

Is Omnix Biopharmaceuticals a good investment or a top pick?

Omnix Biopharmaceuticals was recommended as a Top Pick by on . Read the latest stock experts ratings for Omnix Biopharmaceuticals.

Why is Omnix Biopharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Omnix Biopharmaceuticals worth watching?

In the last year 0 stock analysts on Stockchase covered Omnix Biopharmaceuticals. The stock is worth watching.

What is Omnix Biopharmaceuticals stock price?

On , Omnix Biopharmaceuticals (OMRI-Q) stock closed at a price of $.